ASKA Pharmaceutical Holdings News

ASKA Pharmaceutical Holdings: Tech Doctor and Asuka Pharmaceutical announce the start of joint research on dysmenorrhea under the cooperation of the healthcare application “4MOON”

Sep 24 02:00 ET

ASKA Pharmaceutical Holdings: Subsidiary: Announcement of Personnel Changes at Asuka Pharmaceuticals Co., Ltd.

Aug 23 02:00 ET

ASKA Pharmaceutical Holdings: Announcements of individual stocks regarding personnel changes.

Aug 23 02:00 ET

ASKA Pharmaceutical Holdings: Announcements of individual stocks: Approval has been obtained for the manufacture and sale of the oral contraceptive drospirenone in South Korea.

Aug 16 02:00 ET

ASKA Pharmaceutical Holdings: Announcements of individual stock: Appointment of subsidiary executives and executive officers.

Jun 25 02:00 ET

ASKA Pharmaceutical Holdings: Announcements of individual stocks regarding the job appointment of company executives and executive officers.

Jun 25 02:00 ET

ASKA Pharmaceutical Holdings: Announcements of individual stocks related to the application for manufacturing and sales approval of LF111 (Drosperinone).

Jun 24 02:00 ET

ASKA Pharmaceutical Holdings: License agreement on endometriosis with relugolix compounding agents in the field of gynecological diseases

May 31 02:00 ET

ASKA Pharmaceutical Holdings: Independent Officer Notification Form

May 29 02:00 ET

ASKA Pharmaceutical Holdings: Notice regarding changes in the Company's subsidiary officers and executive officers

Apr 25 02:00 ET

ASKA Pharmaceutical Holdings: Notice regarding changes in officers and executive officers

Apr 25 02:00 ET

ASKA Pharmaceutical Holdings: Notice Concerning Expansion of the Stock Remuneration System with Transfer Restrictions for Executive Officers

Apr 25 02:00 ET

Asuka Pharmaceutical Holdings: Notice regarding achievement of major evaluation items in the LF111 domestic phase III clinical trial

Apr 11 02:00 ET

Asuka Pharmaceutical Holdings: Announcement of the establishment of a “work support support fund” and cancer insurance for employees

Apr 1 02:00 ET

Asuka Pharmaceutical Holdings: Notice of Inauguration, Organizational Changes, and Personnel Changes

Apr 1 02:00 ET

ASKA Pharmaceutical Holdings: Notice of obtaining approval for partial changes in manufacturing and sales approval matters relating to the addition of usage and dosage for children of the hardabsorbable rifamycin antibacterial drug “rifuxima tablets (rifax

Mar 26 02:00 ET

ASKA Pharmaceutical Holdings: Red Arrow Therapeutics and Asuka Pharmaceutical sign a joint research agreement to develop a new treatment for gestational hypertension

Mar 18 02:00 ET

Asuka Pharmaceutical Holdings: Subsidiary: Asuka Pharmaceutical Co., Ltd. Notice regarding organizational and personnel changes

Feb 22 01:00 ET

Asuka Pharmaceutical Holdings: Notice of organizational changes, changes in duties assigned to executive officers, and personnel changes

Feb 22 01:00 ET

ASKA Pharmaceutical Holdings: Notice regarding investment in the “NEXTBLUE2 Investment Limited Partnership,” a fund specializing in the field of women's well-being

Jan 18 01:00 ET